Diarrhea or colorectal cancer: can bacterial toxins serve as a treatment for colon cancer?
Carrithers
S L
SL
Department of Internal Medicine, Division of Infectious Diseases, University of Kentucky, Markey Cancer Center and Lexington Veterans Affairs Medical Center, Lexington, KY 40506, USA. slcaru@uky.edu
D001427:Bacterial Toxins / Q000378:metabolism / Q000627:therapeutic use*; D003110:Colonic Neoplasms / Q000378:metabolism / Q000517:prevention & control / Q000628:therapy*; D003967:Diarrhea / Q000378:metabolism; D004768:Enterotoxins / Q000378:metabolism / Q000627:therapeutic use; D004927:Escherichia coli Infections / Q000378:metabolism; D029968:Escherichia coli Proteins; D006162:Guanylate Cyclase; D006801:Humans; D020935:MAP Kinase Signaling System; D008954:Models, Biological; D011956:Receptors, Cell Surface / Q000378:metabolism; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled; D018000:Receptors, Peptide; D014407:Tumor Cells, Cultured
D001427:Bacterial Toxins; D004768:Enterotoxins; D029968:Escherichia coli Proteins; D011956:Receptors, Cell Surface; D018000:Receptors, Peptide; C034151:heat stable toxin (E coli); D006162:Guanylate Cyclase; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled